Etiology and Outcome of Inflammatory Bowel Disease
Closed Posted
- Opportunity number
- RFA-DP-18-001
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Small Businesses
- For Profit Organizations
- County Governments
- Higher Education Inst. (Public)
- Other
- Public or Indian Housing Auth.
- Higher Education Inst. (Private)
- Tribal Governments (Federally Recognized)
- City/Township Governments
- Special District Governments
- Unrestricted
- State Governments
- Non-501(c)(3) Nonprofits
- Independent School Districts
- Tribal Organizations (Not Federally Recognized)
- 501(c)(3) Nonprofits
Opportunity details come from Grants.gov. Updated .
Synopsis
2 versions
Update #2 · Latest ·
Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is characterized by chronic inflammation of gastrointestinal tract. In 2015, approximately three million US adults reported having a diagnosis of IBD and the estimated number has increased greatly from 1.8 million since 1999. While the exact cause is unknown, the severity and progression of the disease largely impacts the patients' quality of life and imposes huge financial burden to the US healthcare system.The purpose of this announcement is to 1) establish a new IBD registry to estimate incidence of IBD in the adult and pediatric populations and extrapolate to the US population; 2) describe the natural history and outcomes of IBD; 3) determine racial/ethnic variation in the detection and management of IBD; and 4) identify evidence-based strategies to improve disease outcomes. The results are anticipated to enhance understanding of the impact of IBD on the overall health of affected persons and the impact of various clinical practices and healthcare delivery approaches on the disease outcomes.
Update #1 ·
Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is characterized by chronic inflammation of gastrointestinal tract. In 2015, approximately three million US adults reported having a diagnosis of IBD and the estimated number has increased greatly from 1.8 million since 1999. While the exact cause is unknown, the severity and progression of the disease largely impacts the patients’ quality of life and imposes huge financial burden to the US healthcare system.The purpose of this announcement is to 1) establish a new IBD registry to estimate incidence of IBD in the adult and pediatric populations and extrapolate to the US population; 2) describe the natural history and outcomes of IBD; 3) determine racial/ethnic variation in the detection and management of IBD; and 4) identify evidence-based strategies to improve disease outcomes. The results are anticipated to enhance understanding of the impact of IBD on the overall health of affected persons and the impact of various clinical practices and healthcare delivery approaches on the disease outcomes.
Eligibility
None
Files
| File | Type | Posted |
|---|---|---|
| ACTION ITEM.docx | DOCX document | |
| DP18-001 Revision.pdf | ||
| RFA-DP-18-001.pdf | ||
| DP18-001.pdf | ||
| DP18-001.pdf | ||
| RFA-DP-18-001.pdf | ||
| oppRFA-DP-18-001-cfda93.945-cidRFA-DP-18-001-instructions.pdf | ||
| oppRFA-DP-18-001-cfda93.945-cidRFA-DP-18-001.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity